AVTX
Avalo Therapeutics Inc.
$18.03
-$0.00(-0.03%)
52
Overall
60
Value
66
Tech
31
Quality
Market Cap
$155.59M
Volume
108.95K
52W Range
$3.39 - $19.41
Target Price
$33.67
EPS Estimates Overview
| Current Quarter | $-1.67 | Next Quarter | $-1.47 |
| Current Year | $-5.8 | Next Year | $-5.29 |
| QoQ Growth | +12.0% | YoY Growth | +8.8% |
| 3Y EPS CAGR | +91.8% | Target Price | $33.67 |
| Consensus | Buy | Upside | +86.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $18.03 | -0.0% | 108.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |